Human Anti-HIV-1 Env Recombinant Antibody (clone 6B8) (CAT#: MRO-2774CQ)

Recombinant human antibody to Env. 6B8 showed significant binding only to the Gag-Env pseudovirions and not to the gp120 monomer.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 MAb oligomer sensitivity.

Figure 1 MAb oligomer sensitivity.

ELISAs using the indicated antibodies were conducted side-by-side on plates coated with ConA-captured gp120 and oligomer-containing sgp140 (vAE1 supernatant).

Edinger, A. L., Ahuja, M., Sung, T., Baxter, K. C., Haggarty, B., Doms, R. W., & Hoxie, J. A. (2000). Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. Journal of virology, 74(17), 7922-7935.

Neu

Figure 2 Neutralization profiles of antibodies using heterologous SIV isolates.

Figure 2 Neutralization profiles of antibodies using heterologous SIV isolates.

Neutralization assays were conducted as described for SIVmacCP-MAC but using viruses pseudotyped with SIV Env clones SIVmac1A11.

Edinger, A. L., Ahuja, M., Sung, T., Baxter, K. C., Haggarty, B., Doms, R. W., & Hoxie, J. A. (2000). Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. Journal of virology, 74(17), 7922-7935.

Neu

Figure 3 Depicts the neutralization profiles of antibodies using heterologous SIV isolates.

Figure 3 Depicts the neutralization profiles of antibodies using heterologous SIV isolates.

Neutralization assays were conducted as described for SIVmacCP-MAC but using viruses pseudotyped with SIV Env clones SIVmac239.

Edinger, A. L., Ahuja, M., Sung, T., Baxter, K. C., Haggarty, B., Doms, R. W., & Hoxie, J. A. (2000). Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. Journal of virology, 74(17), 7922-7935.

Block

Figure 4 Ability of neutralizing MAbs to block Env-CCR5 binding.

Figure 4 Ability of neutralizing MAbs to block Env-CCR5 binding.

Unpurified SIV-17E-Fr gp120 was preincubated with no antibody (NO AB) or the indicated MAbs for 30 min at RT, added to 293T cells stably expressing rhesus CCR5 or parental 293T cells, and incubated for 1 h at 37°C.

Edinger, A. L., Ahuja, M., Sung, T., Baxter, K. C., Haggarty, B., Doms, R. W., & Hoxie, J. A. (2000). Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelopprotein. Journal of virology, 74(17), 7922-7935.


Specifications

  • Host Species
  • Human
  • Type
  • Human IgG
  • Specificity
  • Recognizes HIV-1 Env
  • Species Reactivity
  • HIV-1
  • Clone
  • 6B8
  • Applications
  • ELISA, Neu

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • The HIV-1 Env antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Neutralization.

Target

  • Alternative Names
  • ENV; gp160; envelope glycoprotein; Envelope surface glycoprotein gp160; precursor; hypothetical protein; Envelope surface glycoprotein gp120; Envelope transmembrane domain

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 6B8"

See other products for "HIV-1 Env"

Single-domain Antibody

CAT Product Name Application Type
NABG-057 Recombinant Anti-HIV-1 env VHH Single Domain Antibody ELISA, IHC, FC, FuncS Llama VHH

Recombinant Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-2774CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare